<scp>TYTOCARE™</scp> home telemonitoring device after radical cystectomy to optimise postoperative outcomes
The TYTOCARE<sup>TM</sup> telemonitoring programme seems to be feasible and highly adhered to by patients and caregivers, with reductions in length of hospital stay, medical complications and hospital readmissions within the first 30 days post-discharge.
Authors
- Matteo Manfredi
- Alberto Quarà
- Marco Colombo
- Enrico Checcucci (ORCID: https://orcid.org/0000-0001-7901-5608)
- Federico Piramide (ORCID: https://orcid.org/0000-0002-3529-9677)
- Alberto Piana (ORCID: https://orcid.org/0000-0001-9247-7938)
- Sabrina De Cillis (ORCID: https://orcid.org/0000-0002-7798-6926)
- Daniele Amparore (ORCID: https://orcid.org/0000-0001-5425-5453)
- Michele Sica (ORCID: https://orcid.org/0000-0002-4166-1468)
- Valentina Garzena
- Francesco Porpiglia
- Cristian Fiori
Institutions
- Candiolo Cancer Institute (IT)
- Ospedale San Luigi Gonzaga (IT)
- University of Turin (IT)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1111/bju.16637
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.15